Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleSupplement

Therapeutic Radiometals Beyond 177Lu and 90Y: Production and Application of Promising α-Particle, β−-Particle, and Auger Electron Emitters

Cristina Müller, Nicholas P. van der Meulen, Martina Benešová and Roger Schibli
Journal of Nuclear Medicine September 2017, 58 (Supplement 2) 91S-96S; DOI: https://doi.org/10.2967/jnumed.116.186825
Cristina Müller
1Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institut, Villigen-PSA, Switzerland
2Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas P. van der Meulen
1Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institut, Villigen-PSA, Switzerland
3Laboratory of Radiochemistry, Paul Scherrer Institut, Villigen-PSA, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martina Benešová
1Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institut, Villigen-PSA, Switzerland
2Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roger Schibli
1Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institut, Villigen-PSA, Switzerland
2Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 58 no. Supplement 2 91S-96S
DOI 
https://doi.org/10.2967/jnumed.116.186825
PubMed 
28864619

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication February 7, 2017
  • Accepted for publication March 13, 2017
  • Published online September 1, 2017.

Copyright & Usage 
© 2017 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Cristina Müller1,2,
  2. Nicholas P. van der Meulen1,3,
  3. Martina Benešová1,2 and
  4. Roger Schibli1,2
  1. 1Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institut, Villigen-PSA, Switzerland
  2. 2Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland; and
  3. 3Laboratory of Radiochemistry, Paul Scherrer Institut, Villigen-PSA, Switzerland
  1. For correspondence or reprints contact: Roger Schibli, Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institut, 5232 Villigen, Switzerland. E-mail: roger.schibli{at}psi.ch
View Full Text

Statistics from Altmetric.com

Cited By...

  • 62 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • New developments in the production of theranostic pairs of radionuclides
    Syed M. Qaim, Bernhard Scholten, Bernd Neumaier
    Journal of Radioanalytical and Nuclear Chemistry 2018 318 3
  • Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nanomedicine
    Francis Man, Peter J. Gawne, Rafael T.M. de Rosales
    Advanced Drug Delivery Reviews 2019 143
  • Rhenium-188 Labeled Radiopharmaceuticals: Current Clinical Applications in Oncology and Promising Perspectives
    Nicolas Lepareur, Franck Lacœuille, Christelle Bouvry, François Hindré, Emmanuel Garcion, Michel Chérel, Nicolas Noiret, Etienne Garin, F. F. Russ Knapp
    Frontiers in Medicine 2019 6
  • Recent advances in theranostics and challenges for the future
    J Harvey Turner
    The British Journal of Radiology 2018 91 1091
  • Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology
    Martha Sahylí Ortega Pijeira, Herlys Viltres, Jan Kozempel, Michal Sakmár, Martin Vlk, Derya İlem-Özdemir, Meliha Ekinci, Seshasai Srinivasan, Amin Reza Rajabzadeh, Eduardo Ricci-Junior, Luciana Magalhães Rebelo Alencar, Mohammed Al Qahtani, Ralph Santos-Oliveira
    EJNMMI Radiopharmacy and Chemistry 2022 7 1
  • Combination of terbium-161 with somatostatin receptor antagonists—a potential paradigm shift for the treatment of neuroendocrine neoplasms
    Francesca Borgna, Stephanie Haller, Josep M. Monné Rodriguez, Mihaela Ginj, Pascal V. Grundler, Jan Rijn Zeevaart, Ulli Köster, Roger Schibli, Nicholas P. van der Meulen, Cristina Müller
    European Journal of Nuclear Medicine and Molecular Imaging 2022 49 4
  • Radiotheranostics with radiolanthanides: Design, development strategies, and medical applications
    Kenji Mishiro, Hirofumi Hanaoka, Aiko Yamaguchi, Kazuma Ogawa
    Coordination Chemistry Reviews 2019 383
  • Theranostic Nuclear Medicine with Gallium-68, Lutetium-177, Copper-64/67, Actinium-225, and Lead-212/203 Radionuclides
    Katherine A. Morgan, Stacey E. Rudd, Asif Noor, Paul S. Donnelly
    Chemical Reviews 2023 123 20
  • Promoting Reactive Oxygen Species Generation: A Key Strategy in Nanosensitizer-Mediated Radiotherapy
    Shichong Jia, Shengfang Ge, Xianqun Fan, Kam W Leong, Jing Ruan
    Nanomedicine 2021 16 9
  • Isotope harvesting at FRIB: additional opportunities for scientific discovery
    E Paige Abel, Mikael Avilov, Virginia Ayres, Eva Birnbaum, Georg Bollen, Greg Bonito, Todd Bredeweg, Hannah Clause, Aaron Couture, Joe DeVore, Matt Dietrich, Paul Ellison, Jonathan Engle, Richard Ferrieri, Jonathan Fitzsimmons, Moshe Friedman, Dali Georgobiani, Stephen Graves, John Greene, Suzanne Lapi, C Shaun Loveless, Tara Mastren, Cecilia Martinez-Gomez, Sean McGuinness, Wolfgang Mittig, David Morrissey, Graham Peaslee, Frederique Pellemoine, J David Robertson, Nicholas Scielzo, Matthew Scott, Gregory Severin, Dawn Shaughnessy, Jennifer Shusterman, Jaideep Singh, Mark Stoyer, Logan Sutherlin, Ate Visser, John Wilkinson
    Journal of Physics G: Nuclear and Particle Physics 2019 46 10

Article usage

Article usage: August 2017 to April 2025

AbstractFullPdf
Aug 2017100
Sep 201791379283
Oct 201745287136
Nov 20172746591
Dec 20172393678
Jan 20182075778
Feb 20182326177
Mar 20181635359
Apr 20181414458
May 20181476654
Jun 20181183233
Jul 2018881631
Aug 2018792425
Sep 2018774015
Oct 2018882831
Nov 2018822126
Dec 2018572221
Jan 20191023219
Feb 2019703317
Mar 2019956133
Apr 20191244345
May 2019696239
Jun 2019303125
Jul 2019472818
Aug 2019772332
Sep 2019443232
Oct 2019424128
Nov 2019453733
Dec 2019342824
Jan 2020354130
Feb 2020442835
Mar 2020482935
Apr 2020322436
May 2020293959
Jun 2020363338
Jul 2020221224
Aug 2020172117
Sep 2020221937
Oct 2020371653
Nov 2020321935
Dec 2020483345
Jan 2021173532
Feb 2021133536
Mar 2021234839
Apr 2021193436
May 2021154139
Jun 2021344747
Jul 2021193633
Aug 2021252828
Sep 2021115051
Oct 2021204856
Nov 2021155334
Dec 2021135639
Jan 2022134035
Feb 2022184934
Mar 2022144931
Apr 20221330238
May 2022195439
Jun 2022105933
Jul 2022234047
Aug 202244121
Sep 2022114538
Oct 2022133932
Nov 2022105537
Dec 202292725
Jan 2023175128
Feb 2023185331
Mar 2023215930
Apr 2023224836
May 2023194837
Jun 2023174841
Jul 2023114524
Aug 2023103930
Sep 2023205439
Oct 2023134920
Nov 2023154320
Dec 2023234938
Jan 202424922
Feb 2024146426
Mar 2024145040
Apr 2024197029
May 2024126131
Jun 2024145835
Jul 2024146826
Aug 2024156219
Sep 202486028
Oct 2024165726
Nov 2024911125
Dec 2024147418
Jan 2025129039
Feb 2025717423
Mar 20251010732
Apr 20251111139
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 58 (Supplement 2)
Journal of Nuclear Medicine
Vol. 58, Issue Supplement 2
September 1, 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Therapeutic Radiometals Beyond 177Lu and 90Y: Production and Application of Promising α-Particle, β−-Particle, and Auger Electron Emitters
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Therapeutic Radiometals Beyond 177Lu and 90Y: Production and Application of Promising α-Particle, β−-Particle, and Auger Electron Emitters
Cristina Müller, Nicholas P. van der Meulen, Martina Benešová, Roger Schibli
Journal of Nuclear Medicine Sep 2017, 58 (Supplement 2) 91S-96S; DOI: 10.2967/jnumed.116.186825

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Therapeutic Radiometals Beyond 177Lu and 90Y: Production and Application of Promising α-Particle, β−-Particle, and Auger Electron Emitters
Cristina Müller, Nicholas P. van der Meulen, Martina Benešová, Roger Schibli
Journal of Nuclear Medicine Sep 2017, 58 (Supplement 2) 91S-96S; DOI: 10.2967/jnumed.116.186825
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • COPPER-67
    • SCANDIUM-47
    • HOLMIUM-166
    • TERBIUM-161
    • TERBIUM-149
    • LEAD-212 (AND BISMUTH 212)
    • ACTINIUM-225
    • BISMUTH-213
    • CONCLUSION
    • DISCLOSURE
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Theranostic Concepts: More Than Just a Fashion Trend--Introduction and Overview
  • Google Scholar

More in this TOC Section

  • Pathway to Approval of Innovative Radiopharmaceuticals in China
  • Recent Advances in Radiotracers Targeting Novel Cancer-Specific Biomarkers in China: A Brief Overview
  • Clinical Implementation of Total-Body PET in China
Show more Supplement

Similar Articles

Keywords

  • radiometals
  • α-particles
  • β−-particles
  • Auger electrons
  • radionuclide therapy
SNMMI

© 2025 SNMMI

Powered by HighWire